Back to search

United Kingdom· GB-APID-45452711000001103

Olmesartan medoxomil 10mg tablets

A medicinal product containing olmesartan, registered in United Kingdom by MSN Laboratories Europe Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedOlmesartan medoxomil 10mg tabletsATC—REGISTER NO.GB-APID-4545271100000…PACKS LISTED1CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Olmesartan
Manufacturer
MSN Laboratories Europe Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    8904159689777

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/94f6c0c7-5252-4122-aebe-210b0ac325cf
GET /v1/drugs/94f6c0c7-5252-4122-aebe-210b0ac325cf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "45452711000001103",
  "desc": "Olmesartan medoxomil 10mg tablets (MSN Laboratories Europe Ltd)",
  "form": "Oral tablet",
  "vpid": "42378111000001108",
  "source": "dmd",
  "vtm_id": "776982004",
  "strength": "10 mg",
  "substance": "Olmesartan",
  "ingredient": "Olmesartan medoxomil",
  "supplier_code": "41521311000001104"
}

See everything about olmesartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.